The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Systematic review of treatments for atopic eczema.
Open accessAbstract
BACKGROUND: Atopic eczema is the commonest inflammatory skin disease of childhood, affecting 15-20% of children in the UK at any one time. Adults make up about one-third of all community cases. Moderate-to-severe atopic eczema can have a profound effect on the quality of life for both sufferers and their families. In addition to the effects of intractable itching, skin damage, soreness, sleep loss and the social stigma of a visible skin disease, other factors such as frequent visits to doctors, special clothing and¿the need to constantly apply messy topical applications all add to the burden of disease. The cause of atopic eczema is unknown, though a genetic pre-disposition and a combination of allergic and non-allergic factors appear to be important in determining disease expression. Treatment of atopic eczema in the UK is characterised by a profusion of treatments aimed at disease control. The evidential basis of these treatments is often unclear. Most people with atopic eczema are managed in primary care where the least research has been done. OBJECTIVES: The objectives of this scoping review are two-fold. To produce an up-to-date coverage 'map' of randomised controlled trials (RCTs) of treatments of atopic eczema. To assist in making treatment recommendations by summarising the available RCT evidence using qualitative and quantitative methods. DATA SOURCES: Data sources included electronic searching of MEDLINE, EMBASE, the Cochrane Controlled Clinical Trials Register, the Cochrane Skin Group specialised register of trials, hand-searching of atopic eczema conference proceedings, follow-up of references in retrieved articles, contact with leading researchers and requests to relevant pharmaceutical companies. INCLUSION/EXCLUSION CRITERIA: Only RCTs of therapeutic agents used in the prevention and treatment of people with atopic eczema of any age were considered for inclusion. Only studies where a physician diagnosed atopic eczema or atopic dermatitis were included. DATA EXTRACTION: Data extraction was conducted by two observers onto abstraction forms, with discrepancies resolved by discussion. QUALITY ASSESSMENT: The quality assessment of retrieved RCTs included an assessment of: a clear description of method and concealment of allocation of randomisation, the degree to which assessors and participants were blinded to the study interventions, and whether all those originally randomised were included in the final main analysis. DATA SYNTHESIS: Where possible, quantitative pooling of similar RCTs was conducted using the Cochrane Collaboration's methods. Where statistical heterogeneity was found, sources of heterogeneity in terms of study participants, formulation or posology of intervention, and use of co-treatments were explored. Where pooling was not deemed to be appropriate, detailed descriptions of the study characteristics and main reported results were presented along with comments on study quality. RESULTS: A total of 1165 possible RCTs were retrieved in hard copy form for further scrutiny. Of these, 893 were excluded from further analysis because of lack of appropriate data. The 272 remaining RCTs of atopic eczema covered at least 47 different interventions, which could be broadly categorised into ten main groups. Quality of reporting was generally poor, and limited statistical pooling was possible only for oral cyclosporin, and only then after considerable data transformation. There was reasonable RCT evidence to support the use of oral cyclosporin, topical corticosteroids, psychological approaches and ultraviolet light therapy. There was insufficient evidence to make recommendations on maternal allergen avoidance for disease prevention, oral antihistamines, Chinese herbs, dietary restriction in established atopic eczema, homeopathy, house dust mite reduction, massage therapy, hypnotherapy, evening primrose oil, emollients, topical coal tar and topical doxepin. (ABSTRACT TRUNCATED)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hay fever, hygiene, and household size.
Strachan, D. P. (1989) · BMJ · doi:10.1136/bmj.299.6710.1259 · Cited by 5,054
Sampson, H. A., & Ho, D. G. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70133-7 · Cited by 1,055
Probiotics: A novel approach in the management of food allergy
Majamaa, H., & Isolauri, E. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70093-9 · Cited by 918
Marshall, M., Lockwood, A., Bradley, C., Adams, C., Joy, C., & Fenton, M. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.3.249 · Cited by 870
Estimation of a Common Effect Parameter from Sparse Follow-Up Data
Greenland, S., & Robins, J. M. (1985) · Biometrics · doi:10.2307/2530643 · Cited by 794
Zeiger, R. S., & Heller, S. (1995) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(95)70074-9 · Cited by 539
A Short-Term Trial of Tacrolimus Ointment for Atopic Dermatitis
Ruzicka, T., Bieber, T., Schöpf, E., Rubins, A., Dobozy, A., Bos, J. D., Jablonska, S., Ahmed, I., Thestrup-Pedersen, K., Daniel, F., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709183371203 · Cited by 518
Chren, M.-M. (1997) · Archives of Dermatology · doi:10.1001/archderm.1997.03890470111018 · Cited by 480
Chren, M. (1997) · Archives of Dermatology · doi:10.1001/archderm.133.11.1433 · Cited by 446
Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis
Tan, B. B., Weald, D., Strickland, I., & Freidmann, P. S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91556-1 · Cited by 426
Cited by
Weidinger, S., & Novak, N. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00149-x · Cited by 1,908
Guidelines of care for the management of atopic dermatitis
Eichenfield, L. F., Tom, W. L., Chamlin, S. L., Feldman, S. R., Hanifin, J. M., Simpson, E. L., Berger, T. G., Bergman, J. N., Cohen, D. E., Cooper, K. D., et al. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.10.010 · Cited by 1,277
Guidelines of care for the management of atopic dermatitis
Eichenfield, L. F., Tom, W. L., Berger, T. G., Krol, A., Paller, A. S., Schwarzenberger, K., Bergman, J. N., Chamlin, S. L., Cohen, D. E., Cooper, K. D., et al. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.03.023 · Cited by 1,224
Quality of life measurement: bibliographic study of patient assessed health outcome measures
Garratt, A., Schmidt, L., Mackintosh, A., & Fitzpatrick, R. (2002) · BMJ · doi:10.1136/bmj.324.7351.1417 · Cited by 1,192
Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., et al. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14891 · Cited by 1,181
Leung, D. Y., & Bieber, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12193-9 · Cited by 1,147
Guidelines of care for the management of atopic dermatitis
Sidbury, R., Davis, D. M., Cohen, D. E., Cordoro, K. M., Berger, T. G., Bergman, J. N., Chamlin, S. L., Cooper, K. D., Feldman, S. R., Hanifin, J. M., et al. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.03.030 · Cited by 885
Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention
Simpson, E. L., Chalmers, J. R., Hanifin, J. M., Thomas, K. S., Cork, M. J., McLean, W. H. I., Brown, S. J., Chen, Z., Chen, Y., & Williams, H. C. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.005 · Cited by 722
Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., et al. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14888 · Cited by 684
Guidelines for treatment of atopic eczema (atopic dermatitis) Part I
Ring, J., Alomar, A., Bieber, T., Deleuran, M., Fink‐Wagner, A., Gelmetti, C., Gieler, U., Lipozencic, J., Luger, T., Oranje, A. P., et al. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04635.x · Cited by 683
Williams, H. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp042803 · Cited by 523
Comorbidities and the impact of atopic dermatitis
Silverberg, J. I. (2019) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2019.04.020 · Cited by 431
Atopic dermatitis: A practice parameter update 2012
Schneider, L., Tilles, S., Lio, P., Boguniewicz, M., Beck, L., LeBovidge, J., Novak, N., Bernstein, D., Blessing-Moore, J., Khan, D., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.672 · Cited by 417
Yosipovitch, G., & Bernhard, J. D. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1208814 · Cited by 405
European S2k Guideline on Chronic Pruritus
Weisshaar, E., Szepietowski, J., Dalgard, F., Garcovich, S., Gieler, U., Giménez-Arnau, A., Lambert, J., Leslie, T., Mettang, T., Misery, L., et al. (2019) · Acta Dermato Venereologica · doi:10.2340/00015555-3164 · Cited by 405
Wahn, U., Bos, J. D., Goodfield, M., Caputo, R., Papp, K., Manjra, A., Dobozy, A., Paul, C., Molloy, S., Hultsch, T., et al. (2002) · Pediatrics · doi:10.1542/peds.110.1.e2 · Cited by 404
Guidelines of care for atopic dermatitis
Hanifin, J. M., Cooper, K. D., Ho, V. C., Kang, S., Krafchik, B. R., Margolis, D. J., Schachner, L. A., Sidbury, R., Whitmore, S. E., Sieck, C. K., et al. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.08.003 · Cited by 387
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II
Ring, J., Alomar, A., Bieber, T., Deleuran, M., Fink‐Wagner, A., Gelmetti, C., Gieler, U., Lipozencic, J., Luger, T., Oranje, A. P., et al. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04636.x · Cited by 360
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
Mollanazar, N. K., Smith, P. K., & Yosipovitch, G. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8488-5 · Cited by 353
Guidelines of care for the management of atopic dermatitis
Sidbury, R., Tom, W. L., Bergman, J. N., Cooper, K. D., Silverman, R. A., Berger, T. G., Chamlin, S. L., Cohen, D. E., Cordoro, K. M., Davis, D. M., et al. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.08.038 · Cited by 326
Berth-Jones, J., Damstra, R. J., Golsch, S., Livden, J. K., Van Hooteghem, O., Allegra, F., & Parker, C. A. (2003) · BMJ · doi:10.1136/bmj.326.7403.1367 · Cited by 320
Hutter, D., Kingdom, J., & Jaeggi, E. (2010) · International Journal of Pediatrics · doi:10.1155/2010/401323 · Cited by 310
ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis
Darsow, U., Wollenberg, A., Simon, D., Taïeb, A., Werfel, T., Oranje, A., Gelmetti, C., Svensson, A., Deleuran, M., Calza, A., et al. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03415.x · Cited by 307
How atopic is atopic dermatitis?
Flohr, C., Johansson, S. G. O., Wahlgren, C.-F., & Williams, H. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.04.027 · Cited by 299
Meggitt, S. J., Gray, J. C., & Reynolds, N. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68340-2 · Cited by 285
Guidelines for diagnosis, prevention, and treatment of hand eczema
Thyssen, J. P., Schuttelaar, M. L. A., Alfonso, J. H., Andersen, K. E., Angelova‐Fischer, I., Arents, B. W. M., Bauer, A., Brans, R., Cannavo, A., Christoffers, W. A., et al. (2022) · Contact Dermatitis · doi:10.1111/cod.14035 · Cited by 282
Persistence of Mild to Moderate Atopic Dermatitis
Margolis, J. S., Abuabara, K., Bilker, W., Hoffstad, O., & Margolis, D. J. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.10271 · Cited by 276
Separate Peripheral Pathways for Pruritus in Man
Namer, B., Carr, R., Johanek, L. M., Schmelz, M., Handwerker, H. O., & Ringkamp, M. (2008) · Journal of Neurophysiology · doi:10.1152/jn.90482.2008 · Cited by 274
Kapp, A., Papp, K., Bingham, A., Fölster-Holst, R., Ortonne, J.-P., Potter, P. C., Gulliver, W., Paul, C., Molloy, S., Barbier, N., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.126500 · Cited by 272
Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency
Aubert‐Wastiaux, H., Moret, L., Le Rhun, A., Fontenoy, A. M., Nguyen, J. M., Leux, C., Misery, L., Young, P., Chastaing, M., Danou, N., et al. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10449.x · Cited by 269
Psychological and educational interventions for atopic eczema in children
Ersser, S. J., Cowdell, F., Latter, S., Gardiner, E., Flohr, C., Thompson, A. R., Jackson, K., Farasat, H., Ware, F., & Drury, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004054.pub3 · Cited by 265
Hanifin, J., Gupta, A. K., & Rajagopalan, R. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.05006.x · Cited by 264
Emollients and moisturisers for eczema
van Zuuren, E. J., Fedorowicz, Z., Christensen, R., Lavrijsen, A. P., & Arents, B. W. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012119.pub2 · Cited by 260
European Guideline on Chronic Pruritus
Weisshaar, E., Szepietowski, J., Darsow, U., Misery, L., Wallengren, J., Mettang, T., Gieler, U., Lotti, T., Lambert, J., Maisel, P., et al. (2012) · Acta Dermato Venereologica · doi:10.2340/00015555-1400 · Cited by 253
Pathophysiology of pruritus in atopic dermatitis: an overview
Ständer, S., & Steinhoff, M. (2002) · Experimental Dermatology · doi:10.1034/j.1600-0625.2002.110102.x · Cited by 252
Dry skin in the elderly: Complexities of a common problem
White-Chu, E. F., & Reddy, M. (2011) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2010.07.005 · Cited by 229
Management of Atopic Dermatitis in the Pediatric Population
Krakowski, A. C., Eichenfield, L. F., & Dohil, M. A. (2008) · Pediatrics · doi:10.1542/peds.2007-2232 · Cited by 205
Dahabreh, I. J., Sheldrick, R. C., Paulus, J. K., Chung, M., Varvarigou, V., Jafri, H., Rassen, J. A., Trikalinos, T. A., & Kitsios, G. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs114 · Cited by 204
Effect of moisturizers on epidermal barrier function
Lodén, M. (2012) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2011.08.015 · Cited by 161
Japanese guidelines for atopic dermatitis 2017
Katayama, I., Aihara, M., Ohya, Y., Saeki, H., Shimojo, N., Shoji, S., Taniguchi, M., & Yamada, H. (2017) · Allergology International · doi:10.1016/j.alit.2016.12.003 · Cited by 149
Hollinghurst, S., Peters, T. J., Kaur, S., Wiles, N., Lewisand, G., & Kessler, D. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.073080 · Cited by 123
Twomey, C., O’Reilly, G., & Byrne, M. (2015) · Family Practice · doi:10.1093/fampra/cmu060 · Cited by 123
Hanifin, J. M., Ellis, C. N., Frieden, I. J., Fölster-Holst, R., Stein Gold, L. F., Secci, A., Smith, A. J., Zhao, C., Kornyeyeva, E., & Eichenfield, L. F. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.04.001 · Cited by 106
Koenig, H. G. (2012) · Depression Research and Treatment · doi:10.1155/2012/460419 · Cited by 41
Prevention or promotion of dryness and eczema by moisturizers?
Lodén, M. (2008) · Expert Review of Dermatology · doi:10.1586/17469872.3.6.667 · Cited by 5
Metadata
- Authors
- Hoare, Po, L. W., & Williams
- Venue
- Health Technology Assessment
- Published
- 2000
- Volume
- 4
- Issue
- 37
- Pages
- 1-191
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W4319293042
- Cited by
- 794
- References
- 123
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.